NIAID Funding News, April 15, 2020

April 15, 2020 NIAID Funding News

Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices

Feature Articles 

NIAID’s Research Response to COVID-19

In leading the U.S. government’s biomedical research response to the pandemic, NIAID is engaged in a multitude of activities focused on vaccine and therapeutic development as well as other priority areas.

Opportunities and Resources

Join the Asthma and Allergic Diseases Cooperative Research Centers

Awardees will integrate innovative, multidisciplinary clinical and translational research to conduct studies on the mechanisms of onset and progression of asthma, allergic, and related diseases.

Funding for Preclinical Development of Countermeasures Against Select Pathogens

NIAID will support milestone-driven projects for preclinical development of lead candidate therapeutics, vaccines, and related countermeasures against select emerging infectious diseases and pathogens.

Develop Long-Acting Treatments for HIV and HIV-Associated Co-Infections

Apply to develop novel safe and effective oral, injectable, implantable, or transdermal drug products with a patient administration goal of once monthly or less.

In The News

Additional Accommodations Accompanying COVID-19 Pandemic Response

A recent NIH notice states that all grant applications submitted late for due dates between March 9, 2020, and May 1, 2020, will be accepted through May 1, 2020.

NIAID Seeks Peer Reviewers With Expertise Relevant to COVID-19 Research

NIAID's Scientific Review Program is looking for experts to serve as peer reviewers for evaluating grant applications and contract proposals focusing on severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019.

eRA Commons Downtime Scheduled for April 17 to 20

NIH will migrate the electronic Research Administration (eRA) website and its modules and data to a cloud platform. During the transition, the eRA website and its modules will be temporarily unavailable.

Attend Virtual Webinars for NIAID Small Business Applicants and Grantees

NIAID’s Small Business Program is hosting a pair of public webinars to cover topics such as developing Phase I and II applications, commercialization plans, budgeting, award management, and the acquisitions process.

Advice Corner

Resolve Bars to Award Quickly and Prepare Just-in-Time Information

Get a quick refresher on the just-in-time process and notifications, including how to examine your summary statement, resolve funding issues, and respond promptly.

Reader Questions

• “Does NIAID maintain a list of open research and development contract solicitations?”
• “Can a principal investigator increase effort by more than 25 percent without NIAID’s prior approval?”

New Funding Opportunities

• RFA-AI-20-029, Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01, Clinical Trial Optional)
• PAR-20-165, Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01, Clinical Trials Not Allowed)
• PAR-20-168, Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21, Clinical Trials Not Allowed)
• Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents
• RFA-AI-20-023, Limited Competition—International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01, Clinical Trial Not Allowed)
• RFA-AI-20-026, Limited Competition—National Biocontainment Laboratories (NBLs) Operations Support (UC7, Clinical Trial Not Allowed)
• NOT-HD-20-008, Notice of Special Interest—Ancillary Reproductive Health Projects to Existing Large and/or Longitudinal Studies
• PA-20-162, Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)

Find other announcements at NIAID Opportunities & Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.